Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
Tenet Healthcare Corporation THC is becoming more aggressive with shareholder returns, and its improving cash generation is making that strategy easier to support. In the first half of 2026, net cash provided by operating activities rose 27.1% year over year to $2.2 billion, while adjusted free cash flow totaled $1.4 billion. That momentum also prompted Tenet Healthcare to raise its 2026 adjusted free cash flow guidance (after noncontrolling interests) to $1.825-$2.055 billion, strengthening the financial backdrop for continued buybacks.
The company has already stepped up repurchases meaningfully. THC spent around $1.4 billion on share buybacks during the first half of 2026, including $1 billion in the second quarter. Its board also increased the repurchase authorization by $2 billion, leaving about $2.1 billion available as of July 23, 2026. This gives THC substantial room to keep returning cash if operating trends remain favorable.
However, buybacks are only one part of the capital-allocation picture. Tenet Healthcare is also investing in USPI expansion, higher-acuity services and other growth initiatives while maintaining sizable capital expenditure requirements. The company expects capital spending of $700-$800 million in 2026, underscoring the need to preserve cash for organic growth alongside shareholder returns. Debt service remains another consideration even after Tenet extended maturities through its recent refinancing.
Thus, the sustainability of Tenet Healthcare’s capital-return strategy hinges on maintaining strong cash conversion while funding growth and managing leverage. If operating momentum holds, THC should have room to remain active on buybacks without significantly limiting investment in its ambulatory platform.
How Are Peers Faring?
Some of THC’s peers in the medical space are Universal Health Services, Inc. UHS and HCA Healthcare, Inc. HCA.
Universal Health Services is also balancing buybacks with sizable reinvestment needs. UHS repurchased $447.5 million of shares in the first half of 2026 and had approximately $977.6 million of remaining share repurchase authorization as of June 30, 2026, although planned capital spending of $950 million-$1.1 billion keeps reinvestment demands elevated.
HCA Healthcare is also maintaining a strong capital-return pace alongside heavy investment. It repurchased shares worth $3.6 billion in the first half of 2026 and paid dividends worth $354 million. As of June 30, 2026, HCA had $7.2 billion remaining under its buyback authorization while keeping its 2026 capital spending outlook at $5-$5.5 billion.
THC’s Price Performance, Valuation & Estimates
Shares of Tenet Healthcare have gained 27.9% over the past year compared with the industry’s growth of 8.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, Tenet Healthcare trades at a forward price-to-earnings ratio of 12.34, above the industry average of 10.89. THC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Tenet Healthcare’s 2026 earnings is pegged at $21.04 per share, implying 25.4% growth from the year-ago period.
Image Source: Zacks Investment Research
THC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpTenet Healthcare Corporation (THC) : Free Stock Analysis Report
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
